Melander RJ - Search Results

1

Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives.

Richardson MA, Furlani RE, Podell BK, Ackart DF, Haugen JD, Melander RJ, Melander C, Basaraba RJ. Richardson MA, et al. Among authors: melander c, melander rj. Tetrahedron Lett. 2015;56(23):3406-3409. doi: 10.1016/j.tetlet.2015.01.122. Tetrahedron Lett. 2015. PMID: 26146419 Free PMC article.

2

Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules.

Ackart DF, Lindsey EA, Podell BK, Melander RJ, Basaraba RJ, Melander C. Ackart DF, et al. Among authors: melander c, melander rj. Pathog Dis. 2014 Apr;70(3):370-8. doi: 10.1111/2049-632X.12143. Epub 2014 Feb 24. Pathog Dis. 2014. PMID: 24478046 Free PMC article.

3

Small-molecule suppression of β-lactam resistance in multidrug-resistant gram-negative pathogens.

Brackett CM, Melander RJ, An IH, Krishnamurthy A, Thompson RJ, Cavanagh J, Melander C. Brackett CM, et al. Among authors: melander c, melander rj. J Med Chem. 2014 Sep 11;57(17):7450-8. doi: 10.1021/jm501050e. Epub 2014 Aug 28. J Med Chem. 2014. PMID: 25137478

4

Controlling bacterial behavior with indole-containing natural products and derivatives.

Melander RJ, Minvielle MJ, Melander C. Melander RJ, et al. Among authors: melander c. Tetrahedron. 2014 Sep 16;70(37):6363-6372. doi: 10.1016/j.tet.2014.05.089. Tetrahedron. 2014. PMID: 25267859 Free PMC article.

5

Thiol-modified gold nanoparticles for the inhibition of Mycobacterium smegmatis.

Gifford JC, Bresee J, Carter CJ, Wang G, Melander RJ, Melander C, Feldheim DL. Gifford JC, et al. Among authors: melander c, melander rj. Chem Commun (Camb). 2014 Dec 28;50(100):15860-3. doi: 10.1039/c4cc06236a. Chem Commun (Camb). 2014. PMID: 25350535 Free PMC article.

6

Innovative strategies for combating biofilm-based infections.

Melander RJ, Melander C. Melander RJ, et al. Among authors: melander c. Adv Exp Med Biol. 2015;831:69-91. doi: 10.1007/978-3-319-09782-4_6. Adv Exp Med Biol. 2015. PMID: 25384664 Review. No abstract available.

7

From worms to targeting virulence factors.

Melander RJ, Melander C. Melander RJ, et al. Among authors: melander c. Chem Biol. 2015 Apr 23;22(4):436-437. doi: 10.1016/j.chembiol.2015.04.005. Chem Biol. 2015. PMID: 25910240

8

Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers.

Furlani RE, Richardson MA, Podell BK, Ackart DF, Haugen JD, Melander RJ, Basaraba RJ, Melander C. Furlani RE, et al. Among authors: melander c, melander rj. Bioorg Med Chem Lett. 2015 Nov 1;25(21):4820-4823. doi: 10.1016/j.bmcl.2015.06.080. Epub 2015 Jun 29. Bioorg Med Chem Lett. 2015. PMID: 26187705 Free PMC article.

9

Potentiation of Francisella Resistance to Conventional Antibiotics through Small Molecule Adjuvants.

Stephens MD, Hubble VB, Ernst RK, van Hoek ML, Melander RJ, Cavanagh J, Melander C. Stephens MD, et al. Among authors: melander c, melander rj. Medchemcomm. 2016 Jan 1;7(1):128-131. doi: 10.1039/C5MD00353A. Epub 2015 Sep 30. Medchemcomm. 2016. PMID: 26877862 Free PMC article.

10

Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent Toxicity.

Brackett CM, Furlani RE, Anderson RG, Krishnamurthy A, Melander RJ, Moskowitz SM, Ernst RK, Melander C. Brackett CM, et al. Among authors: melander c, melander rj. Tetrahedron. 2016 Jun 23;72(25):3549-3553. doi: 10.1016/j.tet.2015.09.019. Tetrahedron. 2016. PMID: 27429479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters